Aethlon Medical Inc.’s stock is currently trading at $0.585 per share, higher by $0.115 or 24.47% for the day on volume of about 2 million shares which is nearly twice the average daily volume. The company’s shares are up after they were highlighted in the October 19th edition of the QualityStocks FREE Daily Newsletter. At that time, the stock was trading for only $0.285 a share, which means that in just a few short days, investors could have more than doubled their money on Aethlon Medical.

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. During the past several weeks, the company has made several announcements concerning the company’s Hemopurifier device. The company had previously reported that the Hemopurifier is effective in capturing exosomes that are secreted by tumors to suppress the immune response in cancer patients. On Tuesday, the company said that the device is also effective in capturing the current pandemic strain of H1N1 swine flu virus.

Our QualityStocks Newsletter, with its emphasis on undiscovered micro-cap and small-cap companies, is like no other newsletter. When investors read the FREE Quality Stocks Daily Newsletter, they are actually viewing data collected from hundreds of small-cap and micro-cap online investment newsletters. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed both in the short and long term. Join the more than 750,000 subscribers and sign up for the QualityStocks newsletter at www.signup.qualitystocks.net.

Let us hear your thoughts below: